INTRODUCTION: Multiple sclerosis (MS) has a variable progression with an early onset of atrophy. Individual longitudinal radiological evaluations (over decades) are difficult to perform due to the limited availability of magnetic resonance imaging (MRI) in the past, patients lost in follow-up, and the continuous updating of scanners. We studied a cohort with widespread disease duration at baseline. The observed individual atrophy rates over time of 10 years represented four decades of disease span. METHODS: Thirty-seven MS patients (age range 24-65 years with disease duration 1-33 years) were consecutively selected and evaluated with MRI at baseline 1995 and in 1996. They were followed up for a decade (mean of 9.25 years, range 7.3-10 years) up to 2003-2005. Brain parenchymal volume and volumes of the supratentorial ventricles were analyzed with semi-automated volumetric measurements at three time points (1995, 1996, and 2003-2005). RESULTS: Volumetric differences were found over shorter periods of time (1-7 months); however, differences vanished by the end of follow-up. A uniform longitudinal decrease in brain volume and increase in ventricle volumes were found. Frontal horn width (1D) correlated strongest to 3D measures. No statistical differences of atrophy rates between MS courses were found. Supratentorial ventricular volumes were associated with disability and this association persisted during follow-up. CONCLUSION: Despite variable clinical courses, the degenerative effects of MS progression expressed in brain atrophy seem to uniformly progress over longer periods of time. These volumetric changes can be detected using 1D and 2D measurements performed on a routine PACS workstation.
INTRODUCTION:Multiple sclerosis (MS) has a variable progression with an early onset of atrophy. Individual longitudinal radiological evaluations (over decades) are difficult to perform due to the limited availability of magnetic resonance imaging (MRI) in the past, patients lost in follow-up, and the continuous updating of scanners. We studied a cohort with widespread disease duration at baseline. The observed individual atrophy rates over time of 10 years represented four decades of disease span. METHODS: Thirty-seven MSpatients (age range 24-65 years with disease duration 1-33 years) were consecutively selected and evaluated with MRI at baseline 1995 and in 1996. They were followed up for a decade (mean of 9.25 years, range 7.3-10 years) up to 2003-2005. Brain parenchymal volume and volumes of the supratentorial ventricles were analyzed with semi-automated volumetric measurements at three time points (1995, 1996, and 2003-2005). RESULTS: Volumetric differences were found over shorter periods of time (1-7 months); however, differences vanished by the end of follow-up. A uniform longitudinal decrease in brain volume and increase in ventricle volumes were found. Frontal horn width (1D) correlated strongest to 3D measures. No statistical differences of atrophy rates between MS courses were found. Supratentorial ventricular volumes were associated with disability and this association persisted during follow-up. CONCLUSION: Despite variable clinical courses, the degenerative effects of MS progression expressed in brain atrophy seem to uniformly progress over longer periods of time. These volumetric changes can be detected using 1D and 2D measurements performed on a routine PACS workstation.
Authors: R H S R Roxburgh; S R Seaman; T Masterman; A E Hensiek; S J Sawcer; S Vukusic; I Achiti; C Confavreux; M Coustans; E le Page; G Edan; G V McDonnell; S Hawkins; M Trojano; M Liguori; E Cocco; M G Marrosu; F Tesser; M A Leone; A Weber; F Zipp; B Miterski; J T Epplen; A Oturai; P Soelberg Sørensen; E G Celius; N Téllez Lara; X Montalban; P Villoslada; A M Silva; M Marta; I Leite; B Dubois; J Rubio; H Butzkueven; T Kilpatrick; M P Mycko; K W Selmaj; M E Rio; M Sá; G Salemi; G Savettieri; J Hillert; D A S Compston Journal: Neurology Date: 2005-04-12 Impact factor: 9.910
Authors: Dana Horakova; Michael G Dwyer; Eva Havrdova; Jennifer L Cox; Ondrej Dolezal; Niels Bergsland; Brett Rimes; Zdenek Seidl; Manuela Vaneckova; Robert Zivadinov Journal: J Neurol Sci Date: 2009-01-24 Impact factor: 3.181
Authors: V L Stevenson; D H Miller; S M Leary; M Rovaris; F Barkhof; B Brochet; V Dousset; M Filippi; R Hintzen; X Montalban; C H Polman; A Rovira; J de Sa; A J Thompson Journal: J Neurol Neurosurg Psychiatry Date: 2000-06 Impact factor: 10.154
Authors: N De Stefano; P M Matthews; M Filippi; F Agosta; M De Luca; M L Bartolozzi; L Guidi; A Ghezzi; E Montanari; A Cifelli; A Federico; S M Smith Journal: Neurology Date: 2003-04-08 Impact factor: 9.910
Authors: Maria José Magraner; Isabel Bosca; Maria Simó-Castelló; Gracian García-Martí; Angel Alberich-Bayarri; Francisco Coret; Jose C Alvarez-Cermeño; Luís Martí-Bonmatí; Luisa M Villar; Bonaventura Casanova Journal: Neuroradiology Date: 2011-02-16 Impact factor: 2.804
Authors: R Zivadinov; N Bergsland; O Dolezal; S Hussein; Z Seidl; M G Dwyer; M Vaneckova; J Krasensky; J A Potts; T Kalincik; E Havrdová; D Horáková Journal: AJNR Am J Neuroradiol Date: 2013-04-11 Impact factor: 3.825
Authors: Hagen H Kitzler; Jason Su; Michael Zeineh; Cynthia Harper-Little; Andrew Leung; Marcelo Kremenchutzky; Sean C Deoni; Brian K Rutt Journal: Neuroimage Date: 2011-09-02 Impact factor: 6.556
Authors: Blake C Jones; Govind Nair; Colin D Shea; Ciprian M Crainiceanu; Irene C M Cortese; Daniel S Reich Journal: Neuroimage Clin Date: 2013-08-13 Impact factor: 4.881
Authors: Zongqi Xia; Lori B Chibnik; Bonnie I Glanz; Maria Liguori; Joshua M Shulman; Dong Tran; Samia J Khoury; Tanuja Chitnis; Todd Holyoak; Howard L Weiner; Charles R G Guttmann; Philip L De Jager Journal: PLoS One Date: 2010-11-30 Impact factor: 3.240